Equifax Inc. (EFX), one of the three major U.S. credit reporting agencies alongside TRU (TransUnion) and EXPGY (Experian), has experienced a challenging twelve months. After trading above $270 as recently as January 2025, the stock has steadily eroded, touching a 52-week low of $150.75 before settling in the mid-$170s. Against this backdrop, the $250 price target has emerged as a widely discussed milestone — it represents the approximate level where the stock traded during the third quarter of 2025 and aligns closely with the lower band of current analyst price targets.
The $250 mark also carries psychological weight. It sits roughly halfway between the 52-week low and the 52-week high, making it a natural recovery target that would signal to the market that Equifax has successfully stabilized its business trajectory. With the average Wall Street price target at approximately $266, the $250 level functions as a realistic intermediate objective that many institutional investors are watching.
Equifax operates as a global data, analytics, and technology company. Its business is organized into three primary segments: U.S. Information Solutions (USIS), which provides credit reporting and scoring services to lenders; Workforce Solutions (EWS), which handles employment and income verification through the TALX platform; and International, which spans operations across Canada, the United Kingdom, Australia, and several other markets. The U.S. market generates roughly 76% of total revenue, making domestic economic conditions the dominant driver of the company's financial performance.
The company generated approximately $6.07 billion in revenue during fiscal 2025 and has maintained an impressive 56.66% gross profit margin. Equifax has also paid dividends for 55 consecutive years, underscoring its financial durability even during periods of economic stress.
At $177.08 per share, Equifax carries a market capitalization of approximately $21.1 billion and an enterprise value near $26.2 billion, reflecting a debt load that adds roughly $5.1 billion beyond equity value. The trailing P/E ratio stands at 31.18, while the forward P/E has compressed to 20.75 based on 2027 earnings estimates. This forward multiple is notably below the stock's five-year historical average, suggesting the market has already priced in a significant degree of macroeconomic pessimism.
The stock currently trades below both its 50-day moving average of $165.56 and its 200-day moving average of $195.01 — though the recent bounce from the $150 area has pushed shares back above the 50-day, a modestly encouraging technical development. The 200-day moving average near $195 represents the first major overhead resistance that must be cleared before any sustained move toward $250 can materialize.
Several factors could support a recovery toward $250. First, Equifax has now largely completed its cloud infrastructure migration, a multi-year investment that weighed on free cash flow but should begin delivering margin benefits as technology spending normalizes. Management guided for approximately 50 basis points of year-over-year margin improvement in 2026, and any upside to that forecast could meaningfully boost earnings per share (EPS).
Second, the Workforce Solutions segment continues to demonstrate resilience, with record additions and double-digit growth in talent and consumer lending verticals. The shift toward longer-term subscription-based government contracts also provides a counter-cyclical buffer that insulates Equifax from pure credit-cycle exposure.
Third, any recovery in mortgage origination activity — which remains depressed with inquiry volumes down roughly 12% year-over-year — would provide a direct revenue tailwind. Housing market data and Federal Reserve interest rate policy will be critical variables to monitor. Should mortgage rates decline meaningfully, the resulting pickup in refinancing and purchase activity could accelerate Equifax's revenue growth beyond current conservative assumptions.
The analyst community maintains a cautiously optimistic stance. Needham & Company reiterated a Buy rating with a $295 price target, citing strong execution despite macro uncertainty. Morgan Stanley holds an Overweight rating with a $280 target, while Wells Fargo is Overweight at $285. On the more conservative side, BMO Capital maintains a Market Perform rating with a $234 target, and Stifel lowered its target to $253 from $295 following third-quarter 2025 results that showed slower-than-expected margin expansion.
The overall consensus is instructive: no analyst currently has a target below $234, meaning even the most bearish professional forecast implies roughly 32% upside from current levels. This near-universal expectation of appreciation provides a meaningful tailwind for the $250 scenario, which sits comfortably within the consensus target range.
The obstacles to reaching $250 are not trivial. The most immediate concern is the trajectory of the U.S. economy. Equifax's core credit reporting business depends directly on lending activity, and any recession or prolonged period of elevated interest rates would suppress loan originations, credit inquiries, and ultimately revenue. The Federal Reserve's posture on rates remains the single most important macro variable for this stock.
Competition from other credit bureaus and emerging fintech data providers represents another risk. TransUnion and Experian continue to invest aggressively in analytics and alternative data capabilities, while new entrants leveraging artificial intelligence and open banking frameworks could gradually erode the traditional credit bureau moat.
The company's elevated debt load — enterprise value exceeds market cap by roughly $5.1 billion — also deserves attention. While leverage ratios have improved following the cloud migration, a volatile corporate credit environment or an unexpected spike in interest expense could pressure earnings and limit multiple expansion. Additionally, the lingering reputational and regulatory overhang from the 2017 cybersecurity breach, while largely resolved, could resurface if new data security incidents emerge in the broader industry.
From a technical analysis perspective, the journey to $250 requires clearing several important zones. The 200-day moving average near $195 serves as the first significant resistance level and a test of whether the recent bounce has genuine momentum. Beyond that, the $210–$220 zone represents a prior support area from late 2025 that has now flipped to resistance, marked by multiple weeks of consolidation during November and December 2025.
The $230–$235 band is particularly significant, as it aligns with the stock's breakdown point from October 2025 and the lower range of analyst targets. A decisive move above $235 would place Equifax in territory not seen since the third quarter of 2025 and would likely attract momentum-oriented institutional buying. On the downside, the $150–$155 zone represents the 52-week low and must hold to preserve the recovery narrative.
Traders seeking real-time guidance on Equifax and thousands of other equities may find value in AI Daily Buy/Sell Signals, a tool developed by Tickeron that leverages artificial intelligence to continuously scan the market and generate actionable Buy, Sell, or Hold signals. The system evaluates shifting market conditions, technical patterns, and AI-driven analytics to help traders identify emerging opportunities, monitor existing positions, and stay ahead of changing trends without manually tracking every data point. For those navigating volatile names like EFX, automated signal generation can serve as a useful complement to traditional research workflows.
A move to $250 for Equifax stock appears realistic but requires a convergence of favorable conditions. The company's forward valuation has compressed to levels that historically attracted buyers, the cloud migration headwind is now largely behind it, and the analyst community is nearly unanimous in projecting substantial upside from current levels. However, the path to $250 depends heavily on macroeconomic variables outside the company's control — most critically, the direction of interest rates and the health of the U.S. mortgage and consumer lending markets.
For Equifax to reclaim $250, investors would likely need to see at least two of the following: a stabilization or improvement in mortgage inquiry volumes, margin expansion exceeding the conservative 50-basis-point guidance, and a broader rotation back into financial and information-services stocks. The first major test will be whether shares can clear the $195–$200 resistance zone and sustain above the 200-day moving average, which would confirm that the recovery from the $150 low has genuine institutional support. Until then, the $250 target remains an achievable but unconfirmed destination.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, EFX has been loosely correlated with TRU. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if EFX jumps, then TRU could also see price increases.
| Ticker / NAME | Correlation To EFX | 1D Price Change % | ||
|---|---|---|---|---|
| EFX | 100% | -2.19% | ||
| TRU - EFX | 65% Loosely correlated | -2.08% | ||
| EXPO - EFX | 56% Loosely correlated | -1.22% | ||
| MSA - EFX | 49% Loosely correlated | +1.30% | ||
| ARLO - EFX | 48% Loosely correlated | -3.09% | ||
| ALLE - EFX | 46% Loosely correlated | +10.45% | ||
More | ||||
| Ticker / NAME | Correlation To EFX | 1D Price Change % |
|---|---|---|
| EFX | 100% | -2.19% |
| Data Processing Services industry (24 stocks) | 36% Loosely correlated | -1.53% |
| Technology Services industry (399 stocks) | 10% Poorly correlated | -1.69% |